faculty UAMS, Chief of Staff WRM
Family Medicine
Dr. Mark S. Thomas, MD
|
|
Give Review
Mark S. Thomas, MD is an expert in the field of Family Medicine. He went to University of Massachusetts Medical School. University of Massachusetts Medical School has a rank of 49 in research and a 12 in primary care He over the years received 1 awards: "Patient-Centered Medical Home Recognition Program". Mark S. Thomas is a published physician. He has 55 papers published. The most current publication "Excess production of phage lambda delayed early proteins under conditions supporting high Escherichia coli growth rates."
Publications
- Regulation of Sulfur Assimilation Pathways in Burkholderia cenocepacia through Control of Genes by the SsuR Transcription Factor.
- A novel method for the production of in vivo-assembled, recombinant Escherichia coli RNA polymerase lacking the α C-terminal domain.
- Anchoring the type VI secretion system to the peptidoglycan: TssL, TagL, TagP... what else?
- Downregulation of the Escherichia coli guaB promoter by upstream-bound cyclic AMP receptor protein.
- The UP element is necessary but not sufficient for growth rate-dependent control of the Escherichia coli guaB promoter.
- Regulation of sulfur assimilation pathways in Burkholderia cenocepacia: identification of transcription factors CysB and SsuR and their role in control of target genes.
- The ornibactin biosynthesis and transport genes of Burkholderia cenocepacia are regulated by an extracytoplasmic function sigma factor which is a part of the Fur regulon.
- Isolation and characterization of Burkholderia cenocepacia mutants deficient in pyochelin production: pyochelin biosynthesis is sensitive to sulfur availability.
- Role of the stationary growth phase sigma factor RpoS of Burkholderia pseudomallei in response to physiological stress conditions.
- Toxicity of the bacteriophage lambda cII gene product to Escherichia coli arises from inhibition of host cell DNA replication.
- Cardiovascular magnetic resonance imaging.
- Determinants of the C-terminal domain of the Escherichia coli RNA polymerase alpha subunit important for transcription at class I cyclic AMP receptor protein-dependent...
- The other pro choice - pro life issue: a comparison of euthanasia law in the United States and the Netherlands.
- Identification of an enhancer element for the endosperm-specific expression of high molecular weight glutenin.
- Molecular cloning and characterisation of the gua regulatory region of Escherichia coli K12.
- Cell surface expression of CD154 inhibits alloantibody responses: A mechanism for the prevention of autoimmune responses against activated T cells?
- Regulation of alpha operon gene expression in Escherichia coli. A novel form of translational coupling.
- Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
- Nucleotide sequence and organisation of the gua promoter region of Escherichia coli.
- Enhancement of immunogenicity of recombinant antigens by production of a cytokine-antigen fusion protein for vaccination.
- Translational regulation of the L11 ribosomal protein operon of Escherichia coli: mutations that define the target site for repression by L1.
- Fusion of antigen to Fas-ligand in a DNA vaccine enhances immunogenicity.
- Escherichia coli rpoA mutation which impairs transcription of positively regulated systems.
- Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA.
- An interferon gamma-gp120 fusion delivered as a DNA vaccine induces enhanced priming.
- pGSTp: an IVET-compatible promoter probe vector conferring resistance to trimethoprim.
- A nested set of C-terminal deletions of the alpha subunit of Escherichia coli RNA polymerase define regions concerned with assembly, proteolysis, stabilization and tra...
- The effect of a nested set of C-terminal substituted deletions on the function of the alpha subunit of Escherichia coli RNA polymerase.
- Iron acquisition mechanisms of the Burkholderia cepacia complex.
- Visualization and functional assessment of proximal and middle left anterior descending coronary stenoses in humans with magnetic resonance imaging.
- Assessment of coronary arterial restenosis with phase-contrast magnetic resonance imaging measurements of coronary flow reserve.
- Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiog...
- Secondary attachment site for bacteriophage lambda in the guaB gene of Escherichia coli.
- DNA binding and DNA bending by the MelR transcription activator protein from Escherichia coli.
- Architecture of Fis-activated transcription complexes at the Escherichia coli rrnB P1 and rrnE P1 promoters.
- Transcription activation at the Escherichia coli melAB promoter: the role of MelR and the cyclic AMP receptor protein.
- Involvement of the Escherichia coli RNA polymerase alpha subunit in transcriptional activation by the bacteriophage lambda CI and CII proteins.
- Modulation of the susceptibility of intestinal bacteria to bacteriophages in response to Ag43 phase variation -- a hypothesis.
- Impaired lysogenisation of the Escherichia coli rpoA341 mutant by bacteriophage lambda is due to the inability of CII to act as a transcriptional activator.
- In vivo expression technology identifies a type VI secretion system locus in Burkholderia pseudomallei that is induced upon invasion of macrophages.
- The cell surface protein Ag43 facilitates phage infection of Escherichia coli in the presence of bile salts and carbohydrates.
- Excess production of phage lambda delayed early proteins under conditions supporting high Escherichia coli growth rates.
- The Escherichia coli RNA polymerase alpha subunit and transcriptional activation by bacteriophage lambda CII protein.
- An RNA polymerase alpha subunit mutant impairs N-dependent transcriptional antitermination in Escherichia coli.
- Drastically decreased transcription from CII-activated promoters is responsible for impaired lysogenization of the Escherichia coli rpoA341 mutant by bacteriophage lam...
- UP element-dependent transcription at the Escherichia coli rrnB P1 promoter: positional requirements and role of the RNA polymerase alpha subunit linker.
- The Burkholderia cepacia fur gene: co-localization with omlA and absence of regulation by iron.
- The Escherichia coli RNA polymerase alpha subunit linker: length requirements for transcription activation at CRP-dependent promoters.
- Escherichia coli can tolerate insertions of up to 16 amino acids in the RNA polymerase alpha subunit inter-domain linker.
- Role of the RNA polymerase alpha subunits in CII-dependent activation of the bacteriophage lambda pE promoter: identification of important residues and positioning of ...
- The C-terminal domain of the Escherichia coli RNA polymerase alpha subunit plays a role in the CI-dependent activation of the bacteriophage lambda pM promoter.
- Genetic analysis of bacteriophage lambdaN-dependent antitermination suggests a possible role for the RNA polymerase alpha subunit in facilitating specific functions of...
- Downregulation of the Escherichia coli guaB promoter by FIS.
- The pobA gene of Burkholderia cenocepacia encodes a group I Sfp-type phosphopantetheinyltransferase required for biosynthesis of the siderophores ornibactin and pyoche...
Schools
University of Massachusetts Worcester Campus
University Of Ok College Med Tulsa
Doctors Specialties
- Family Medicine
Accepted Insurances
- American Republic
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Standard Network PPO
- CoreSource
- Coventry Health Care
- Coventry Health Care of Tennessee PPO
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Medicare Advantage PFFS
- Choice Care PPO
- Medicare MCR
- Qualchoice PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- Patient-Centered Medical Home Recognition Program
Education
-
University of Massachusetts Medical School
Drug Facts
| NPI NUMBER | 1699755942 | |
| NPPES Provider LastName | THOMAS | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 727645379 | |
| NPPES Provider State | AR | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 1667.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 47.0 | |
| Percent Opioid Claims | 2.82 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699755942 |
| Last Name Of The Provider | THOMAS |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Mark A. Bonner, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neal Roberts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John N. Redwine, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janette Nesheiwat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah B. Bibb, MD
This Doctor is OpenDoctor Recommended.
|